Apeloa Pharmaceutical Co LtdH3.E32Apeloa
Founded 37 years ago, Apeloa achieves annual sales of USD 1.4 billion.
Around 30% of our sales are generated from Europe, the United States and Japan.
We operate 8 production sites, with a total reactor capacity of 19,090 m³. The group has over 7,000 global employees, among whom more than 1,300 are R&D chemists.
Our facilities have passed **40+ official audits by FDA, EDQM and PMDA**. We invest over USD 70 million every year in ESG initiatives.